
Sign up to save your podcasts
Or
Bivalent mRNA COVID-19 vaccines were recommended for children and adolescents aged 5 to 17 years in the US, but were they effective? JAMA Associate Editor Tracy A. Lieu, MD, MPH, spoke with author Leora R. Feldstein, PhD, US Centers for Disease Control and Prevention, about the effectiveness of bivalent COVID-19 vaccines in children and adolescents. Related Content:
4.3
106106 ratings
Bivalent mRNA COVID-19 vaccines were recommended for children and adolescents aged 5 to 17 years in the US, but were they effective? JAMA Associate Editor Tracy A. Lieu, MD, MPH, spoke with author Leora R. Feldstein, PhD, US Centers for Disease Control and Prevention, about the effectiveness of bivalent COVID-19 vaccines in children and adolescents. Related Content:
489 Listeners
37 Listeners
8 Listeners
17 Listeners
19 Listeners
14 Listeners
11 Listeners
5 Listeners
7 Listeners
9 Listeners
22 Listeners
86 Listeners
5 Listeners
29 Listeners
15 Listeners
5 Listeners
19 Listeners
3 Listeners
162 Listeners